Common TitleSURVEYOR-II (Part 3)
Official Title Glecaprevir/Pibrentasvir for HCV Genotype 3 Patients with Cirrhosis and/or Prior Treatment Experience: A Partially Randomized Phase III Clinical Trial.
Phase Phase III
ClinicalTrials.gov NCT02243293
Treatments
Glecaprevir-Pibrentasvir![Glecaprevir-Pibrentasvir Mavyret](//cdn.hepatitisc.uw.edu/css/images/drugs/22.png)
![Glecaprevir-Pibrentasvir Mavyret](http://cdn.hepatitisc.uw.edu/css/images/drugs/22.png)
Glecaprevir-Pibrentasvir
Tradename:MavyretOther Names:GLE-PIBClass:FDA-ApprovedFunding
IndustryAbbVie